Another oral antiviral treatment, but still far away from hepatitis B virus cure

According to this study, 4-year viral suppression is still far from achieving HBsAg clearance [5], which is also compatible with other clinical studies using different NA treatments [6,7]. In addition to host factors, including age and sex [15], surrogate markers for liver fibrosis have shown their potential to improve the prediction performance of current HCC prediction models [16,17]. Tai-Chung Tseng Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan